Chapter 1: The Challenge of Medication Adherence

Ensuring timely medication intake is crucial for effective disease management. Personally, I have witnessed this challenge with my mother, who manages multiple health conditions and relies on a pill organizer. While this tool is helpful, complications can arise, especially for someone over 75. A simple spill can undo all efforts to maintain her regimen.

Surprisingly, this is a widespread issue. Research indicates that around 50% of individuals do not adhere to their prescribed medications correctly. This non-adherence can lead to significant health risks, including diminished treatment effectiveness, disease advancement, and additional complications. To combat this, scientists at Rice University have developed a solution that allows a single dose to last for several months.

“Approximately half of all patients fail to take their medications as directed. With this method, a single injection can sustain them for months.”

~ Kevin McHugh, Corresponding Author of the Study

To illustrate the staggering impact of medication non-adherence, consider the United States, where it contributes to over 100,000 deaths annually, nearly 25% of hospital admissions, and healthcare expenses exceeding $100 billion. Although the idea of using microparticles for time-released medication is not entirely new, researchers at Rice University have introduced an innovative method to tackle this issue.

Chapter 2: PULSED Technology Explained

Researchers have created a groundbreaking technology known as PULSED (Particles Uniformly Liquified and Sealed to Encapsulate Drugs), which employs advanced 3D printing and soft lithography techniques. This enables the production of over 300 biodegradable cylinders that are small and safe enough to be injected with standard needles. This approach ensures that medication is delivered effectively and minimizes side effects.

The microcylinders are made from PLGA, a polymer commonly used in medical treatments. The team investigated four different drug-loading methods and adjusted the PLGA composition to control the dissolution rate of the particles, achieving release periods ranging from 10 days to nearly five weeks.

The innovative sealing technique developed by the researchers was a significant advancement that emerged from their experiments. McHugh noted that while prior research focused on PLGA microparticles for drug encapsulation, achieving a reliable sealing method had proven challenging and costly for practical applications. However, after refining their approach, the team successfully established a straightforward sealing process, which became a critical step in the production of these time-released drug capsules. Each array of cylinders, measuring 22x14, is comparable in size to a postage stamp and is produced on glass microscope slides.

The first video explores various regenerative medicine therapies, including the use of neural progenitor cells, which could play a role in these innovative drug delivery systems.

In another insightful video, researchers discuss how studying genetic variations can provide valuable insights into cardiac arrhythmias, further enhancing our understanding of medication adherence and its implications.

The complete research findings were published in the Journal of Advanced Materials.

Stay updated with relevant stories by following my content on Medium.